PUMA expression is significantly reduced in human cutaneous melanomas

Alison M Karst1, Derek L Dai, Magdalena Martinka

  • 1Department of Medicine, Division of Dermatology, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.

Oncogene
|February 4, 2005
PubMed

Insights

Reduced PUMA (p53 upregulated modulator of apoptosis) expression correlates with poorer survival in melanoma patients. Restoring PUMA levels induces cancer cell death, suggesting its potential as a prognostic marker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cutaneous malignant melanoma is an aggressive skin cancer with poor prognosis and chemoresistance.
  • Dysregulation of apoptotic pathways is implicated in melanoma chemoresistance.
  • The role of PUMA (p53 upregulated modulator of apoptosis) in melanoma is not well understood.

Purpose of the Study:

  • To investigate the role of PUMA in human melanoma formation, progression, and survival.
  • To determine if PUMA expression levels correlate with patient prognosis.
  • To assess the therapeutic potential of PUMA in melanoma.

Main Methods:

  • Tissue microarray and immunohistochemistry used to analyze PUMA expression in 107 primary melanomas, 51 metastatic melanomas, and 64 dysplastic nevi.
  • Statistical analysis to correlate PUMA expression with patient survival.
  • Exogenous PUMA expression induced in human melanoma cell lines to evaluate apoptotic response.

Main Results:

  • PUMA expression was significantly lower in primary melanomas than in dysplastic nevi (P<0.0001).
  • PUMA expression was further reduced in metastatic melanomas compared to primary tumors (P=0.001).
  • Weak PUMA expression correlated with poorer overall and disease-specific 5-year survival (P<0.005 and P<0.001, respectively) and was an independent predictor of survival (P=0.05).
  • Exogenous PUMA expression induced significant apoptotic cell death in melanoma cell lines.

Conclusions:

  • PUMA expression is reduced during melanoma progression and correlates with poor patient survival.
  • PUMA may serve as a valuable prognostic marker for human melanoma.
  • Adenoviral delivery of PUMA sensitizes melanoma cells to apoptosis, indicating potential therapeutic applications.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...